Filing Details
- Accession Number:
- 0001288123-11-000076
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-10-03 11:19:39
- Reporting Period:
- 2011-09-30
- Filing Date:
- 2011-10-03
- Accepted Time:
- 2011-10-03 11:19:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1098972 | Agenus Inc | AGEND | Biological Products, (No Disgnostic Substances) (2836) | 061562417 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 935679 | H Garo Armen | 162 Fifth Avenue Suite 900 New York NY 10010 | Chairman & Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-09-30 | 16,666 | $2.99 | 911,363 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-10-03 | 3,966 | $3.33 | 915,329 | No | 4 | J | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | J | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 831,142 | Indirect | by trusts, Armen Partners, and Antigenics Holdings LLC |
Footnotes
- Represents an open market purchase of 100,000 pre-split shares adjusted for the 1:6 reverse stock split effective October 3, 2011.
- Dr. Armen is trustee and has investment authority for the Garo Armen 2009 2 Year GRAT and the Garo Armen 2009 4 Year GRAT, each holding 211,850 and 363,969 shares of Agenus Inc. common stock, respectively. Dr. Armen disclaims beneficial ownership therein. Dr. Armen is the General Partner of Armen Partners LP. As of the date of this report Armen Partners owns a total of 251,277 shares of Agenus Inc. common stock. Dr. Armen is also the CEO, Chairman of the Board of Managers and a member of Antigenics Holdings LLC ("Holdings") which, as of the date of this report owns 4,046 shares of Agenus Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Armen Partners and Holdings and disclaims beneficial ownership except to the extent of his pecuniary interest therein.
- Represents the issuance of stock for payment of 34% of Dr. Armen's base salary for the month of September 2011.
Billionaire Hedge Funds
